ESR1 and breast carcinoma: Based on molecular and histological properties, breast cancer can broadly be divided into three groups: luminal-type (estrogen receptor/progesterone receptor-positive (ER+)), human epidermal growth factor receptor 2 (HER2) positive, and triple-negative [9].